Ranibizumab pretreatment in diabetic vitrectomy:a pilot randomised controlled trial (the RaDiVit study)

Autor: D Fabinyi, L da Cruz, Philip Hykin, D G Charteris, Oliver Comyn, Louisa Wickham, James W B Bainbridge, Tunde Peto, G W Aylward, Wen Xing, Z Gregor, E Ezra, P M Sullivan, Catey Bunce, Marie Restori

Publikováno v: Comyn, O, Wickham, L, Charteris, D G, Sullivan, P M, Ezra, E, Gregor, Z, Aylward, G W, da Cruz, L, Fabinyi, D, Peto, T, Restori, M, Xing, W, Bunce, C, Hykin, P G & Bainbridge, J W 2017, ' Ranibizumab pretreatment in diabetic vitrectomy : a pilot randomised controlled trial (the RaDiVit study) ', Eye (London, England), vol. 31, pp. 1253–1258 . https://doi.org/10.1038/eye.2017.75

Purpose: Our aim was to evaluate the impact of intravitreal ranibizumab pretreatment on the outcome of vitrectomy surgery for advanced proliferative diabetic retinopathy. The objective was to determine the feasibility of a subsequent definitive trial

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68ea8bea715d443b7f3c4faf2f3d7fa1
https://kclpure.kcl.ac.uk/ws/files/78225152/Ranibizumab_pre_treatment_in_Diabetic_COMYN_Publishedonline12May2017_GREEN_AAM.pdf

Suppurative keratitis caused by Streptococcus pneumoniae after cataract surgery

Autor: M Armstrong, D G Charteris, M Batterbury, A B Tullo

Publikováno v: British Journal of Ophthalmology. 78:847-849

Six elderly patients are described (age range 76-86 years) in whom a characteristic peripheral suppurative keratitis developed 1-36 months after uncomplicated cataract surgery. A corneal section had been used in all patients and four or five interrup

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::653dce5fc14add2dea23d5cca3e7d8f5
https://doi.org/10.1136/bjo.78.11.847

Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy : Results from a randomized, double-blind, controlled clinical trial

Autor: R H, Asaria, C H, Kon, C, Bunce, D G, Charteris, D, Wong, P T, Khaw, G W, Aylward

Publikováno v: Ophthalmology. 108(7)

To assess the safety and efficacy of adjuvant combination therapy using 5-fluorouracil (5-FU) and low molecular weight heparin (LMWH) for prevention of proliferative vitreoretinopathy (PVR) after vitrectomy and retinal reattachment surgery.Prospectiv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9b3ae71bbdc080cad070c935b8a5dd75
https://pubmed.ncbi.nlm.nih.gov/11986080

Soluble TNF receptors in vitreoretinal proliferative disease

Autor: G A, Limb, R D, Hollifield, L, Webster, D G, Charteris, A H, Chignell

Publikováno v: Investigative ophthalmologyvisual science. 42(7)

To measure vitreous levels of soluble TNF-receptors (sTNF-Rs) types I and II in eyes with rhegmatogenous retinal detachment (RRD), uncomplicated or complicated with proliferative vitreoretinopathy (PVR), and in eyes with proliferative diabetic retino

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3017ac74e29bf0b2eacf4380a184e898
https://pubmed.ncbi.nlm.nih.gov/11381065

Ophthalmic molluscum contagiosum: clinical and immunopathological features

Autor: D G Charteris, R E Bonshek, A B Tullo

Publikováno v: The British journal of ophthalmology. 79(5)

AIMS--A study of ophthalmic molluscum contagiosum infection was undertaken to define its clinical presentation and immunopathological features. METHODS--Retrospective analysis of 35 cases of histologically proved molluscum contagiosum infection was c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d3e6d543d7e45ca1b6f6e4ada8ae46b
https://pubmed.ncbi.nlm.nih.gov/7612562